SCHEMBL30719557

SCHEMBL30719557

COc1ncc(C)cc1S(=O)(=O)Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.39
SLC13A5 Q86YT5 2/20 0.36
SLC13A2 Q13183 1/20 0.36
SLC13A3 Q8WWT9 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3R1 P27986 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
PTGS2 P35354 1/20 0.35
CCR9 P51686 1/20 0.35
CCR4 P51679 3/20 0.35
ALDH1A1 P00352 1/20 0.34
ALPL P05186 1/20 0.34
GAA P10253 1/20 0.34
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
RECQL P46063 1/20 0.33
NFE2L2 Q16236 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22532403 1.00 TRPV4 (0.39) TRPV4SLC13A5SLC13A2SLC13A3PIK3CD
SCHEMBL10289346 0.84 PTGS2 (0.42) SLC13A5SLC13A2SLC13A3PIK3CDPIK3R1
SCHEMBL19040355 0.83 TRPV4 (0.40) TRPV4SLC13A5PTGS2ALPLSMN1; SMN2
SCHEMBL20304474 0.82 TRPV4 (0.46) TRPV4PIK3CACCR4ALPLNFE2L2
SCHEMBL25226442 0.81 APLNR (0.35) TRPV4PTGS2CCR9ALDH1A1
SCHEMBL27103224 0.81 MEN1 (0.41) TRPV4CCR4ALPLSMN1; SMN2
SCHEMBL22532346 0.81 TRPV4 (0.38) TRPV4PIK3CACCR4ALPLSCN9A
SCHEMBL11918252 0.79 TSHR (0.43) SLC13A5SLC13A2SLC13A3PIK3CDPIK3R1
SCHEMBL31535985 0.78 PTGS2 (0.40) TRPV4PIK3CDPIK3R1PIK3CAPIK3CB
SCHEMBL22531857 0.77 TRPV4 (0.44) TRPV4CCR4ALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612131-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2025-09-10 EP disclosed
EP-4554934-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF Biogen MA Inc. (US) 2025-05-21 EP disclosed
WO-2024095003-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2024-05-10 WO disclosed
WO-2024015503-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2024-01-18 WO disclosed